CO5540381A2 - Derivados de imidazotriacinonas y su uso contra procesos inflamatorios y/o enfermedades inmunitarias - Google Patents

Derivados de imidazotriacinonas y su uso contra procesos inflamatorios y/o enfermedades inmunitarias

Info

Publication number
CO5540381A2
CO5540381A2 CO03108302A CO03108302A CO5540381A2 CO 5540381 A2 CO5540381 A2 CO 5540381A2 CO 03108302 A CO03108302 A CO 03108302A CO 03108302 A CO03108302 A CO 03108302A CO 5540381 A2 CO5540381 A2 CO 5540381A2
Authority
CO
Colombia
Prior art keywords
optionally substituted
imidazotriacinonas
derivatives
inflammatory processes
immune diseases
Prior art date
Application number
CO03108302A
Other languages
English (en)
Spanish (es)
Inventor
Cristina Alonso-Alija
Gielen Heike
Martin Hendrix
Niewohner Ulrich
Schauss Dagmar
Bischoff Hilmar
Burkhardt Nils
Geiss Volker
Karl-Heinz Schlemmer
J Cuthbert Nigel
Mary Fitzgerald
Sturton Graham
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of CO5540381A2 publication Critical patent/CO5540381A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CO03108302A 2001-06-01 2003-12-10 Derivados de imidazotriacinonas y su uso contra procesos inflamatorios y/o enfermedades inmunitarias CO5540381A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0113344.6A GB0113344D0 (en) 2001-06-01 2001-06-01 Novel heterocycles 3

Publications (1)

Publication Number Publication Date
CO5540381A2 true CO5540381A2 (es) 2005-07-29

Family

ID=9915717

Family Applications (1)

Application Number Title Priority Date Filing Date
CO03108302A CO5540381A2 (es) 2001-06-01 2003-12-10 Derivados de imidazotriacinonas y su uso contra procesos inflamatorios y/o enfermedades inmunitarias

Country Status (28)

Country Link
US (2) US7115602B2 (enExample)
EP (1) EP1399447A1 (enExample)
JP (1) JP2004536078A (enExample)
KR (1) KR20040023605A (enExample)
CN (1) CN1512993A (enExample)
BG (1) BG108381A (enExample)
BR (1) BR0210910A (enExample)
CA (1) CA2449095A1 (enExample)
CO (1) CO5540381A2 (enExample)
CZ (1) CZ295609B6 (enExample)
EC (1) ECSP034872A (enExample)
EE (1) EE200300570A (enExample)
GB (1) GB0113344D0 (enExample)
GT (1) GT200200099A (enExample)
HR (1) HRP20031090A2 (enExample)
HU (1) HUP0400773A3 (enExample)
MX (1) MXPA03010985A (enExample)
NO (1) NO20035324D0 (enExample)
NZ (1) NZ529848A (enExample)
PE (1) PE20030231A1 (enExample)
PL (1) PL366906A1 (enExample)
RU (1) RU2003138078A (enExample)
SK (1) SK14672003A3 (enExample)
SV (1) SV2003001061A (enExample)
UA (1) UA75149C2 (enExample)
UY (1) UY27312A1 (enExample)
WO (1) WO2002098879A1 (enExample)
ZA (1) ZA200309111B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2388111A (en) * 2002-05-01 2003-11-05 Bayer Ag Novel imidazotriazinone compounds
GB2388594A (en) * 2002-05-16 2003-11-19 Bayer Ag Imidazo-triazine PDE 4 inhibitors
FR2850653A1 (fr) * 2003-02-04 2004-08-06 Univ Pasteur Derives de pyrazolotriazine, procede de preparation et utilisations
JP2006219374A (ja) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Pde7阻害作用を有するイミダゾトリアジノン誘導体
AR058071A1 (es) * 2005-10-03 2008-01-23 Astrazeneca Ab Derivados de dihidropirazolo (3,4-e)(1,4)diazepina. procesos de obtencion y composiciones farmaceuticas.
WO2012123406A1 (en) 2011-03-17 2012-09-20 Algiax Pharmaceuticals Gmbh Novel use of imidazotriazinones
WO2013156231A1 (en) * 2012-04-16 2013-10-24 Algiax Pharmaceuticals Gmbh Use of imidazotriazinones in neuropathic pain
US20170119775A1 (en) * 2014-03-28 2017-05-04 Algiax Pharmaceuticals Gmbh Treatment of cognitive disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791025A (fr) * 1971-11-19 1973-05-07 Allen & Hanburys Ltd Composes heterocycliques
GB1457873A (en) 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
DK109578A (da) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
HU227841B1 (en) 1997-11-12 2012-05-02 Bayer Pharma AG 2-phenyl substituted imidazotriazinones, process for their preparation and pharmaceutical compositions thereof
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
CA2323008C (en) * 1999-10-11 2005-07-12 Pfizer Inc. Pharmaceutically active compounds

Also Published As

Publication number Publication date
SK14672003A3 (sk) 2004-08-03
UA75149C2 (en) 2006-03-15
HRP20031090A2 (en) 2005-08-31
CZ20033275A3 (en) 2004-03-17
US7115602B2 (en) 2006-10-03
UY27312A1 (es) 2003-02-28
NO20035324L (no) 2003-11-28
HUP0400773A2 (hu) 2004-07-28
JP2004536078A (ja) 2004-12-02
HUP0400773A3 (en) 2007-09-28
EP1399447A1 (en) 2004-03-24
ECSP034872A (es) 2004-01-28
MXPA03010985A (es) 2004-10-28
KR20040023605A (ko) 2004-03-18
US20050065153A1 (en) 2005-03-24
PL366906A1 (en) 2005-02-07
CN1512993A (zh) 2004-07-14
BG108381A (bg) 2004-11-30
NZ529848A (en) 2006-02-24
GB0113344D0 (en) 2001-07-25
CA2449095A1 (en) 2002-12-12
NO20035324D0 (no) 2003-11-28
ZA200309111B (en) 2004-11-24
SV2003001061A (es) 2003-03-18
BR0210910A (pt) 2004-06-08
PE20030231A1 (es) 2003-05-16
WO2002098879A1 (en) 2002-12-12
RU2003138078A (ru) 2005-05-27
US20030139415A1 (en) 2003-07-24
EE200300570A (et) 2004-04-15
GT200200099A (es) 2003-02-13
CZ295609B6 (cs) 2005-08-17

Similar Documents

Publication Publication Date Title
CY1107236T1 (el) Παραγωγα της 2-αμινο-3-(αλκυλο)-πυριμιδονης ως gsk3. βητα αναστολεις
CY1110064T1 (el) Παραγωγα φαινυλ-πιπεραζινης ως αναστολεις επαναπροσληψης σεροτονινης
CY1108792T1 (el) Παραγωγα διοξανιου-2-αλκυλκαρβαμικου, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη
PE20060570A1 (es) Compuestos de quinazolina e isoquinolina piperidilo sustituidos como inhibidores de fosfodiesterasa pde-10
CY1105915T1 (el) Παραγωγα θειαζολιου για τη θepαπεια των παθησεων που σχετιζονται με τους ppar
AR106237A2 (es) Inhibidores heterocíclicos de la aspartil proteasa, sus sales farmacéuticamente aceptables
DOP2011000301A (es) Derivados de azaadamantano y metodos de uso de los mismos
HRP20080664A2 (hr) Supstituirani piridinski herbicidi
ECSP088149A (es) 3-acilaminobenzanilidas insecticidas
DK1483265T3 (da) Purinderivater som kinaseinhibitorer
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
AR072224A1 (es) Derivados de pirimidona sustituidos
AR044706A2 (es) Procedimientos para preparar 4-aminoquinolinas, inhibidores de cetp
CY1106132T1 (el) Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
UY29446A1 (es) Derivados de ciclopentapiridina y tetrahidroquinolina
CY1109072T1 (el) Βητα κρυσταλλικη μορφη του υδροχλωρικου αλατος της ιβαμπραδινης, μεθοδος παρασκευης αυτου και φαρμακευτικης συνθεσεις που το περιεχουν
TW200640916A (en) (1,5-diphenyl-1H-pyrazol-3-yl)oxadiazole derivatives, their preparation and their application in therapeutics
NO20061317L (no) Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
AR045326A1 (es) Derivados de aminoquinolina y su uso como ligandos a3 de adenosina
CO5040027A1 (es) Mezclas fungicidas de eteres fenilbencilicos y/o cabamatos con dinitrofenoles, procedimieto para combatir hongos dani- nos con dichas mezclas; utiliacion de dichos compuestos en la preparacion de dichas mezclas y agentes fungicidas for- mulados con d
CO6311082A2 (es) Derivados de sulfonil-quinolina, procesos para su preparación y composiciones farmacéuticas que los contienen
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
AR046768A1 (es) Derivados de piridin-tetrazol, metodos de obtencion y composiciones farmaceuticas
EA200600601A1 (ru) Производные аминопиридина в качестве ингибиторов индуцируемой no-синтазы

Legal Events

Date Code Title Description
FC Application refused